Antiviral Susceptibilities of Distinct Lineages of Influenza C and D Viruses
Viruses · 2023
DOI: 10.3390/v15010244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Emi Takashita und 11 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo 208-0011, Japan. Hauptthemen laut MEDLINE: Influenza, Human, Orthomyxoviridae. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Labour and Welfare, Japan, JSPS KAKENHI.
Abstract (Originalsprache)
The emergence and spread of antiviral-resistant influenza viruses are of great concern. To minimize the public health risk, it is important to monitor antiviral susceptibilities of influenza viruses. Analyses of the antiviral susceptibilities of influenza A and B viruses have been conducted globally; however, those of influenza C and D viruses are limited. Here, we determined the susceptibilities of influenza C viruses representing all six lineages (C/Taylor, C/Yamagata, C/Sao Paulo, C/Aichi, C/Kanagawa, and C/Mississippi) and influenza D viruses representing four lineages (D/OK, D/660, D/Yama2016, and D/Yama2019) to RNA polymerase inhibitors (baloxavir and favipiravir) by using a focus reduction assay. All viruses tested were susceptible to both drugs. We then performed a genetic analysis to check for amino acid substitutions associated with baloxavir and favipiravir resistance and found that none of the viruses tested possessed these substitutions. Use of the focus reduction assay with the genotypic assay has proven valuable for monitoring the antiviral susceptibilities of influenza C and D viruses as well as influenza A and B viruses. Antiviral susceptibility monitoring of all influenza virus types should continue in order to assess the public health risks posed by these viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.
- Department of Veterinary Microbiology, Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo 113-8657, Japan.
- Department of Infectious Diseases, Yamagata University Faculty of Medicine, Yamagata 990-9585, Japan.
- Department of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata 990-0031, Japan.
- Virus Research Center, Clinical Research Division, Sendai Medical Center, Sendai 983-8520, Japan.
ORCID-Profile: Emi Takashita, Shin Murakami
Förderung
- Ministry of Health, Labour and Welfare, Japan
- JSPS KAKENHI
Zitieren
APA
Takashita, E., Murakami, S., Matsuzaki, Y., Fujisaki, S., Morita, H., Nagata, S., Katayama, M., Mizuta, K., Nishimura, H., Watanabe, S., Horimoto, T., & Hasegawa, H. (2023). Antiviral Susceptibilities of Distinct Lineages of Influenza C and D Viruses. Viruses. https://doi.org/10.3390/v15010244
Vancouver
Takashita E, Murakami S, Matsuzaki Y, Fujisaki S, Morita H, Nagata S, et al. Antiviral Susceptibilities of Distinct Lineages of Influenza C and D Viruses. Viruses. 2023. doi:10.3390/v15010244
BibTeX
@article{Takashita2023,
author = {Takashita, Emi and Murakami, Shin and Matsuzaki, Yoko and Fujisaki, Seiichiro and Morita, Hiroko and Nagata, Shiho and Katayama, Misa and Mizuta, Katsumi and Nishimura, Hidekazu and Watanabe, Shinji and Horimoto, Taisuke and Hasegawa, Hideki},
title = {Antiviral Susceptibilities of Distinct Lineages of Influenza C and D Viruses},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15010244}
}
EUVIMED